Celiac Disease Drug Market Scope
Celiac disease is an autoimmune disease in which the lining of the small intestine is damaged when the intake of gluten food is higher. This disease can lead to various health problems such as miscarriage or infertility, intestinal cancer, seizures, gall bladder malfunction, neurological manifestation of the disease, stunted growth in children, and birth defects.
The market study is being classified, by Application (Hospitals, Clinics and Other) and major geographies with country level break-up.
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Celiac Disease Drug market throughout the predicted period.
F. Hoffmann-La Roche (Switzerland), Johnson & Johnson (United States), Merck (United States), Pfizer (United States), ADMA Biologics (United States), Amgen (United States), Anthera Pharmaceuticals (United States), Bayer (Germany), Biogen (United States), BioLineRx (Israel) and Biotest (Germany) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Bristol-Myers Squibb (United States), Celgene (United States), Takeda Pharmaceutical (Japan), Novartis (Switzerland), LFB Group (United States) and Kedrion Biopharma (United States).
AdvanceMarketAnalytics has segmented the market of Global Celiac Disease Drug market by Type, Application and Region.
On the basis of geography, the market of Celiac Disease Drug has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
"Currently, there is no FDA-approved drug for the treatment of celiac disease. The only course of action available to celiac patients is to adhere to a strict, gluten-free diet, despite mounting evidence the diet alone is not enough for many of those suffering from ongoing symptoms and intestinal damage."
- Research and Development in Healthcare Industry
- Increasing Awareness about the Healthcare Industry
- An Upsurge in Disposable Income among the Population
- Higher Consumption of Gluten-Containing Food
- Ongoing Research on Celiac Disease Drug
- Drugs have a Side Effect on the Immune System
- Complex Regulation on These Drugs in Numerous Countries
Key Target AudienceCeliac Disease Drug Manufacturer, Celiac Disease Drug Supplier/Distributor, Raw Material Supplier, Government Bodies and Research Institutes
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase